|
NAA16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.386400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.183000E-01 |
| Normal-vs-Stage2 |
6.687200E-01 |
| Normal-vs-Stage3 |
9.723800E-02 |
| Normal-vs-Stage4 |
2.222800E-03 |
| Stage1-vs-Stage2 |
5.133000E-01 |
| Stage1-vs-Stage3 |
1.001430E-01 |
| Stage1-vs-Stage4 |
9.369800E-04 |
| Stage2-vs-Stage3 |
1.449590E-01 |
| Stage2-vs-Stage4 |
2.235600E-02 |
| Stage3-vs-Stage4 |
1.758010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.106210E-01 |
| Normal-vs-AfricanAmerican |
5.595200E-01 |
| Normal-vs-Asian |
1.349630E-02 |
| Caucasian-vs-AfricanAmerican |
6.169900E-02 |
| Caucasian-vs-Asian |
1.227630E-02 |
| AfricanAmerican-vs-Asian |
1.417210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.130420E-01 |
| Normal-vs-Female |
8.160800E-01 |
| Male-vs-Female |
1.184820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.864200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.048600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.014300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.705600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.639200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.128800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.677800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.673800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.399200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.222300E-02 |
| Normal-vs-Grade 2 |
5.586000E-01 |
| Normal-vs-Grade 3 |
2.747700E-02 |
| Normal-vs-Grade 4 |
2.356100E-04 |
| Grade 1-vs-Grade 2 |
7.505900E-02 |
| Grade 1-vs-Grade 3 |
2.044300E-02 |
| Grade 1-vs-Grade 4 |
5.017000E-03 |
| Grade 2-vs-Grade 3 |
9.760700E-04 |
| Grade 2-vs-Grade 4 |
2.47730000002555E-06 |
| Grade 3-vs-Grade 4 |
2.794300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.283600E-01 |
| Normal-vs-ccB subtype |
4.695900E-02 |
| ccA subtype-vs-ccB subtype |
3.498100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.915800E-01 |
| Normal-vs-N1 |
1.872100E-02 |
| N0-vs-N1 |
1.442380E-01 |
|
|
